Evidence map›Paper›PMID 34449808›Full record

ArticlePloS one2021

Neurovascular imaging with QUTE-CE MRI in APOE4 rats reveals early vascular abnormalities.

Joshua Leaston, Craig F Ferris, Praveen Kulkarni, Dharshan Chandramohan, Anne L van de Ven, Ju Qiao, Liam Timms, Jorge Sepulcre, Georges El Fakhri, Chao Ma and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Joshua LeastonImaginostics, Inc., Cambridge, Massachusetts, United States of America.ORCID 0000-0002-1250-800X
Craig F FerrisDepartment of Psychology, Northeastern University, Boston, Massachusetts, United States of America.
Praveen KulkarniDepartment of Psychology, Northeastern University, Boston, Massachusetts, United States of America.
Dharshan ChandramohanImaginostics, Inc., Cambridge, Massachusetts, United States of America.
Anne L van de VenDepartment of Physics, Northeastern University, Boston, Massachusetts, United States of America.
Ju QiaoCenter for Translational Neuroimaging, Northeastern University, Boston, Massachusetts, United States of America.
Liam TimmsDepartment of Physics, Northeastern University, Boston, Massachusetts, United States of America.
Jorge SepulcreGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Georges El FakhriGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Chao MaGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Marc D NormandinGordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Codi GharagouzlooImaginostics, Inc., Cambridge, Massachusetts, United States of America.ORCID 0000-0002-9427-3696
Northeastern University · USHarvard University · US

Funding

Postgraduate Training Program in Medical Imaging (PTPMI)T32EB013180 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Ciprian Catana, Pedram Heidari · 2011 to 2026
$3.7M
Howard Hughes Medical InstituteNIBIB NIH HHS T32 EB013180
6 · The paper itself

Abstract

Cerebrovascular abnormality is linked to Alzheimer's disease and related dementias (ADRDs). ApoE-Ɛ4 (APOE4) is known to play a critical role in neurovascular dysfunction, however current medical imaging technologies are limited in quantification. This cross-sectional study tested the feasibility of a recently established imaging modality, quantitative ultra-short time-to-echo contrast-enhanced magnetic resonance imaging (QUTE-CE MRI), to identify small vessel abnormality early in development of human APOE4 knock-in female rat (TGRA8960) animal model. At 8 months, 48.3% of the brain volume was found to have significant signal increase (75/173 anatomically segmented regions; q<0.05 for multiple comparisons). Notably, vascular abnormality was detected in the tri-synaptic circuit, cerebellum, and amygdala, all of which are known to functionally decline throughout AD pathology and have implications in learning and memory. The detected abnormality quantified with QUTE-CE MRI is likely a result of hyper-vascularization, but may also be partly, or wholly, due to contributions from blood-brain-barrier leakage. Further exploration with histological validation is warranted to verify the pathological cause. Regardless, these results indicate that QUTE-CE MRI can detect neurovascular dysfunction with high sensitivity with APOE4 and may be helpful to provide new insights into health and disease.

Indexed as

AnimalsApolipoprotein E4Blood-Brain BarrierBrainDisease Models, AnimalGene Knock-In TechniquesHumansMagnetic Resonance ImagingRatsApolipoprotein E4

Identifiers

PMID34449808
PMCPMC8396782
OpenAlexW3194174663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.